Naoki Hasegawa

InstitutionKeio University School of Medicine
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 4 publications in April 2021
    All Publications
    Bar chart showing 166 publications over 20 distinct years, with a maximum of 21 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sekiguchi K, Watanabe N, Miyazaki N, Ishizuchi K, Iba C, Tagashira Y, Uno S, Shibata M, Hasegawa N, Takemura R, Nakahara J, Takizawa T. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study. Cephalalgia. 2021 Aug 18; 3331024211038654. PMID: 34407651.
      Citations: 1     Fields:    
    2. Uchida S, Uwamino Y, Uno S, Nagata M, Aoki W, Murata M, Kitagawa Y, Hasegawa N. Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan. J Clin Virol. 2021 09; 142:104915. PMID: 34315009.
      Citations: 1     Fields:    Translation:Humans
    3. Nishimura T, Uwamino Y, Uno S, Kashimura S, Shiraki T, Kurafuji T, Morita M, Noguchi M, Azegami T, Yamada-Goto N, Murai-Takeda A, Yokoyama H, Kuwabara K, Kato S, Matsumoto M, Hirata A, Iida M, Harada S, Ishizaka T, Misawa K, Murata M, Saya H, Amagai M, Kitagawa Y, Takeuchi T, Mori M, Takebayashi T, Hasegawa N. SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan. Intern Med. 2021 Aug 15; 60(16):2569-2575. PMID: 34148952.
      Citations: 1     Fields:    Translation:Humans
    4. Uwamino Y, Nagata M, Aoki W, Nakagawa T, Inose R, Yokota H, Furusawa Y, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Kawaoka Y, Hasegawa N, Murata M. Accuracy of rapid antigen detection test for nasopharyngeal swab specimens and saliva samples in comparison with RT-PCR and viral culture for SARS-CoV-2 detection. J Infect Chemother. 2021 Jul; 27(7):1058-1062. PMID: 33934920.
      Citations: 3     Fields:    Translation:Humans
    5. Abe K, Shimura T, Takenouchi T, Iwasaki YW, Ishizu H, Uwamino Y, Uno S, Gotoh J, Tachikawa N, Takeuchi Y, Katayama J, Nozaki H, Fujii S, Seki S, Nakamura M, Uda K, Misumi T, Ishihara J, Yamada K, Kanai T, Murai S, Araki K, Ebihara T, Siomi H, Hasegawa N, Kitagawa Y, Amagai M, Suematsu M, Kosaki K. Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C. Keio J Med. 2021 Jun 25; 70(2):44-50. PMID: 33853975.
      Citations:    Fields:    Translation:Humans
    6. Wakui M, Uwamino Y, Kurafuji T, Noguchi M, Ohno A, Yokota H, Kikuchi H, Hasegawa N, Saya H, Murata M. Assessment of humoral responses in COVID-19 using various quantitative antibody tests. Ann Clin Biochem. 2021 07; 58(4):368-376. PMID: 33730868.
      Citations:    Fields:    Translation:Humans
    7. Kondo Y, Kaneko Y, Takei H, Tamai H, Kabata H, Suhara T, Yamamoto R, Nagata H, Ishii M, Sasaki J, Hasegawa N, Fukunaga K, Takeuchi T. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease. Clin Exp Rheumatol. 2021 May-Jun; 39(3):631-638. PMID: 33886458.
      Citations: 1     Fields:    Translation:Humans
    8. Fukushima T, Kabata H, Yamamoto R, Suhara T, Uwamino Y, Kondo Y, Masaki K, Kamata H, Nagata H, Homma K, Kaneko Y, Ishii M, Sasaki J, Morisaki H, Hasegawa N, Fukunaga K. The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia. Respir Investig. 2021 May; 59(3):360-363. PMID: 33582075.
      Citations: 3     Fields:    Translation:Humans
    9. Uwamino Y, Wakui M, Aoki W, Kurafuji T, Yanagita E, Morita M, Nagata M, Inose R, Noguchi M, Yokota H, Hasegawa N, Saya H, Murata M. Evaluation of the usability of various rapid antibody tests in the diagnostic application for COVID-19. Ann Clin Biochem. 2021 May; 58(3):174-180. PMID: 33334135.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    10. Harada S, Uno S, Ando T, Iida M, Takano Y, Ishibashi Y, Uwamino Y, Nishimura T, Takeda A, Uchida S, Hirata A, Sata M, Matsumoto M, Takeuchi A, Obara H, Yokoyama H, Fukunaga K, Amagai M, Kitagawa Y, Takebayashi T, Hasegawa N. Control of a Nosocomial Outbreak of COVID-19 in a University Hospital. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa512. PMID: 33330740.
      Citations: 10     
    11. Uchida S, Uno S, Uwamino Y, Hashimoto M, Matsumoto S, Obara H, Jinzaki M, Kitagawa Y, Hasegawa N. CT screening for COVID-19 in asymptomatic patients before hospital admission. J Infect Chemother. 2021 Feb; 27(2):232-236. PMID: 33172767.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    12. Uwamino Y, Nagata M, Aoki W, Fujimori Y, Nakagawa T, Yokota H, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Shiraki T, Uchida S, Uno S, Kabata H, Ikemura S, Kamata H, Ishii M, Fukunaga K, Kawaoka Y, Hasegawa N, Murata M. Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2. J Clin Pathol. 2021 01; 74(1):67-68. PMID: 32928941.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    13. Ishii M, Terai H, Kabata H, Masaki K, Chubachi S, Tateno H, Nakamura M, Nishio K, Koh H, Watanabe R, Ueda S, Terashima T, Suzuki Y, Yagi K, Miyao N, Minematsu N, Inoue T, Nakachi I, Namkoong H, Okamori S, Ikemura S, Kamata H, Yasuda H, Kawada I, Hasegawa N, Fukunaga K. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study. J Infect. 2020 11; 81(5):e3-e5. PMID: 32920063.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    14. Okamori S, Lee H, Kondo Y, Akiyama Y, Kabata H, Kaneko Y, Ishii M, Hasegawa N, Fukunaga K. Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. Medicine (Baltimore). 2020 Aug 28; 99(35):e21804. PMID: 32871900.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    15. Kondo Y, Kaneko Y, Oshige T, Fukui H, Saito S, Okayama M, Kamata H, Ishii M, Hasegawa N, Fukunaga K, Takeuchi T. Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus. Ann Rheum Dis. 2021 05; 80(5):e77. PMID: 32759254.
      Citations: 10     Fields:    Translation:Humans
    16. Nakagawara K, Masaki K, Uwamino Y, Kabata H, Uchida S, Uno S, Asakura T, Funakoshi T, Kanzaki S, Ishii M, Hasegawa N, Fukunaga K. Acute onset olfactory/taste disorders are associated with a high viral burden in mild or asymptomatic SARS-CoV-2 infections. Int J Infect Dis. 2020 Oct; 99:19-22. PMID: 32726723.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    17. Imai T, Takahashi K, Hoshuyama T, Hasegawa N, Chia SE, Koh D. Substantial differences in preparedness for emergency infection control measures among major hospitals in Japan: lessons from SARS. J Infect Chemother. 2006 Jun; 12(3):124-31. PMID: 16826344.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    Hasegawa's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (350)
    Explore
    _
    Co-Authors (143)
    Explore
    _
    Similar People (60)
    Explore
    _